JPMORGAN CHASE & CO - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 26 filers reported holding ACER THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$57
+26.7%
70
+45.8%
0.00%
Q2 2023$45480.0%0.00%
Q1 2023$0480.0%0.00%
Q4 2022$0480.0%0.00%
Q3 2022$0480.0%0.00%
Q2 2022$0480.0%0.00%
Q1 2022$0480.0%0.00%
Q4 2021$0480.0%0.00%
Q3 2021$0480.0%0.00%
Q2 2021$0480.0%0.00%
Q1 2021$0480.0%0.00%
Q4 2020$0480.0%0.00%
Q3 2020$0480.0%0.00%
Q2 2020$0
-100.0%
48
-99.7%
0.00%
Q1 2020$33,000
-56.0%
16,594
-11.3%
0.00%
Q4 2019$75,000
+1400.0%
18,709
+1007.0%
0.00%
Q3 2019$5,000
-93.2%
1,690
-92.1%
0.00%
Q2 2019$73,000
-80.6%
21,268
+37.3%
0.00%
Q1 2019$376,000
+102.2%
15,488
+67.6%
0.00%
Q4 2018$186,000
-30.6%
9,242
+6.2%
0.00%
Q3 2018$268,000
+26700.0%
8,704
+19242.2%
0.00%
Q2 2018$1,0000.0%450.0%0.00%
Q1 2018$1,000
-88.9%
45
-93.0%
0.00%
Q4 2017$9,0006450.00%
Other shareholders
ACER THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Nantahala Capital Management 1,136,416$1,049,3670.10%
Anson Funds Management LP 129,795$119,8530.02%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 60,000$550.01%
Hudson Bay Capital Management LP 274,300$253,2890.00%
UBS Group AG 33$300.00%
RHUMBLINE ADVISERS 347$3200.00%
OSAIC HOLDINGS, INC. 200$1840.00%
WELLS FARGO & COMPANY/MN 132$1220.00%
NORTHERN TRUST CORP 22,231$20,5280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ACER THERAPEUTICS INC shareholders